Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty

Effect of a Walking Skill Training Program in Patients Who Have Undergone Total Hip Arthroplasty: Followup One Year After Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00808483

Enrollment

Registered

2008-12-15

Start date

2008-10-31

Completion date

2011-04-30

Last updated

2015-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Hip, Exercise Therapy

Keywords

total hip arthroplasty, physical functioning, training program, self-efficacy, exercise therapy, walking

Brief summary

Rehabilitation plays an important part after total hip arthroplasty. In this common practice few studies have been performed on this issue. The aims of this study were: 1. to examine the immediate effects of a walking skill training program on walking, stair climbing, balance, self-reported physical functioning physical functioning, pain and self-efficacy compared to a control group without supervised physiotherapy 2. to examine whether the effects persisted 12 months after surgery

Interventions

OTHERWalking skill training program

12 individualized training sessions containing functional exercises like walking, stair climbing, balance training and with supervision and guidance from a physiotherapist.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* Primary cox arthrosis * Good written and oral Norwegian language

Exclusion criteria

* Severe hip arthrosis in the other hip or severe gon arthrosis that restricted walking * Neurological disorders * Rheumatoid arthritis

Design outcomes

Primary

Measure	Time frame	Description
6 Minutes Walk Test (6MWT)	5 months and 12 months	Participants walked in a 40 meter hospital corridor for 6 minutes.

Secondary

Measure	Time frame	Description
Hip Dysfunction and Osteoarthritis Outcome Score (HOOS)	5 months and 12 months	Self-reported symptoms, pain, physical function, function in sport and recreation, quality of life. 0 (worse) - 100 (best)
Harris Hip Score (HHS)	5 months and 12 months	Pain and physical function. 0 (worse) - 100 (best)
Self-efficacy	5 months and 12 months	Self-reported self-efficacy in activities. 0 (worse) - 100 (best).
Stair Climbing Test (ST)	5 months and 12 months	Ascend and descend 8 steps with a step hight of 16 cm as fast as they could without running. Few seconds (best) - many seconds (worse)
Index of Muscle Function (IMF)	5 months and 12 months	Tests of general mobility, muscle strength, balance/coordination, and endurance. 40 (worse) - 0 (best)
Figure-of-eight Test	5 months and 12 months	Test of dynamic balance. Number of steps on and outside the line is registered. 0 (best)
ROM Extension	5 months and 12 months	Active range of motion (ROM) in hip extension test. Degrees is registered. 0 degrees indicates zero position of the hip, minus digrees indicates flexion contracture.

Countries

Norway

Participant flow

Recruitment details

Participants were recruited at the hospital the day before surgery from October 2008 to March 2010.

Participants by arm

Arm	Count
Walking Skill Training Group 12 sessions of participation in the walking skill training program. Walking skill training program: 12 individualized training sessions containing functional exercises like walking, stair climbing, balance training and sit-to-stand with guidance and supervision from a physiotherapist.	35
Control Group No participation in the walking skill training group	33
Total	68

Withdrawals & dropouts

Period	Reason	FG000	FG001
From 3 to 5 Months After Surgery	Lack of Efficacy	1	0
From 3 to 5 Months After Surgery	Withdrawal by Subject	1	1
From 5 Months to 12 Months	Lack of Efficacy	1	0

Baseline characteristics

Characteristic	Walking Skill Training Group	Control Group	Total
Age, Continuous	65 years	66 years	66 years
BMI	27 kg/m^2	27 kg/m^2	27 kg/m^2
Sex: Female, Male Female	21 Participants	14 Participants	35 Participants
Sex: Female, Male Male	14 Participants	19 Participants	33 Participants

Adverse events

Event type	EG000 affected / at risk	EG001 affected / at risk
deaths Total, all-cause mortality	— / —	— / —
other Total, other adverse events	0 / 35	0 / 33
serious Total, serious adverse events	0 / 35	0 / 33